gut microbiota
The Human Gut Microbiome Reference Material (RM) promises to standardize and enhance research efforts in a field poised to transform healthcare.
Inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis, are long-term conditions involving gut inflammation caused by an excessive immune response. Now, a study done in mice found…
The findings of a recent study suggest a potential role of gut microbiota and microbial metabolites in the link between sugar-sweetened beverages intake and diabetes risk.
Emil Chuang, Chief Medical Officer at Intrinsic Medicine, explores the growing understanding of gut-brain axis disorders and the potential of Human Milk Oligosaccharides (HMOs) in their treatment.
Positive results from Phase 1 trial of BL-001, an innovative live biotherapeutic product (LBP) designed to replicate the metabolic effects of the ketogenic diet.
A new database of thousands of gut microbiota samples from across the word highlights the need for more diverse microbiota research across the globe.
The approval is major step forward in the fight against recurrent C. diff infection.
David Paez-Espino, Co-founder & CTO at Ancilia Biosciences, discusses the use of CRISPR technology to develop a new class of bacterial therapies that address critical gaps in microbiome-based treatments.
Researchers have developed a new approach to restore the gut microbiota by combining a high-fiber, plant-based diet with supplementation of beneficial microbes such as Limosilactobacillus reuteri.
The microbiota plays a protective role against colorectal cancer by regulating Snhg9.
